Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP51631.RAobAZX8MV-T-2DLuxsfbMoJ9R2GWzOwlxafB1TK0SbUc130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51631.RAobAZX8MV-T-2DLuxsfbMoJ9R2GWzOwlxafB1TK0SbUc130_provenance.
• NP53308.RAs_sTLJ3B1o8ri6QBWvIwK3h74xwl1I0O-d5tddpMbF8130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53308.RAs_sTLJ3B1o8ri6QBWvIwK3h74xwl1I0O-d5tddpMbF8130_provenance.
• NP55341.RAljSpWuzCffsQ9nK-EZoz6Zf77UQUk0Hhus7tdU7A4Ds130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55341.RAljSpWuzCffsQ9nK-EZoz6Zf77UQUk0Hhus7tdU7A4Ds130_provenance.
• NP48216.RAZ71KlWmUI1nW7SFsPX78Awwzw9I1XJbbCzy73rQUAko130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP48216.RAZ71KlWmUI1nW7SFsPX78Awwzw9I1XJbbCzy73rQUAko130_provenance.
• NP50789.RASt-zD1-KAaIp_CTPMOFEpnguoHsoTyqNdGWpkjyF654130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50789.RASt-zD1-KAaIp_CTPMOFEpnguoHsoTyqNdGWpkjyF654130_provenance.
• NP68929.RAWpA0cjYpzGsLLC5LxVIuBPvFZxSwsTpSjkIrJ6BoFLI130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68929.RAWpA0cjYpzGsLLC5LxVIuBPvFZxSwsTpSjkIrJ6BoFLI130_provenance.
• NP74292.RASF0mi7S_It93myCkeJw97kzrMTHK87OabkM7zo_L8to130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74292.RASF0mi7S_It93myCkeJw97kzrMTHK87OabkM7zo_L8to130_provenance.
• NP74548.RAb-QMT8vU-5TKeYz3Gr2_r6fh1oEF3RAAcWboEb2uZJo130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74548.RAb-QMT8vU-5TKeYz3Gr2_r6fh1oEF3RAAcWboEb2uZJo130_provenance.
• NP77890.RA1fjgLL9oXATe0bRZs33lisItMP5K0IpS5WMKBNAg3hI130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77890.RA1fjgLL9oXATe0bRZs33lisItMP5K0IpS5WMKBNAg3hI130_provenance.
• NP89690.RAq0DGYcoQz6hR-eqfOsuL6HFc16DyHh1A6RisFtd_T_U130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89690.RAq0DGYcoQz6hR-eqfOsuL6HFc16DyHh1A6RisFtd_T_U130_provenance.
• NP83798.RAIXztJdmmPE_AYcfsbjoCq5gjVFGJXe85kEvODpZGNZQ130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83798.RAIXztJdmmPE_AYcfsbjoCq5gjVFGJXe85kEvODpZGNZQ130_provenance.
• NP63986.RAdhbAYyu56FrMYUArc5lA_DnRwRKIZyzFM4YGmm5Nrao130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63986.RAdhbAYyu56FrMYUArc5lA_DnRwRKIZyzFM4YGmm5Nrao130_provenance.
• NP77188.RAC6lDFa1LrHwfn0vYjqBBRRhM7KZQNmvoTtSzZ70NS1M130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77188.RAC6lDFa1LrHwfn0vYjqBBRRhM7KZQNmvoTtSzZ70NS1M130_provenance.
• NP48338.RA9fy9CS36etPU_vi68Snn6iXFiBEvzUXxZIURv5KGzYc130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP48338.RA9fy9CS36etPU_vi68Snn6iXFiBEvzUXxZIURv5KGzYc130_provenance.
• NP48497.RA3IagRauFuv0ciR4CNWw4SzkgdI9FBZ_H1in853PzNiA130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP48497.RA3IagRauFuv0ciR4CNWw4SzkgdI9FBZ_H1in853PzNiA130_provenance.
• NP50773.RA60OrwJ6-PqtuAqOY1y711TGMe9YHWJFsLIVGdc1BMkY130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50773.RA60OrwJ6-PqtuAqOY1y711TGMe9YHWJFsLIVGdc1BMkY130_provenance.
• NP56985.RA7Ku4hkoXj7OCSKsmhpeerRM4tgouoNv_z-urOCx7Rxg130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP56985.RA7Ku4hkoXj7OCSKsmhpeerRM4tgouoNv_z-urOCx7Rxg130_provenance.
• NP63995.RA05j5JPmu5DGMBtOufI5g-G94WSgMx7WwC67Op0AHKXI130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63995.RA05j5JPmu5DGMBtOufI5g-G94WSgMx7WwC67Op0AHKXI130_provenance.
• NP75945.RA0xX85VN3KC2bqP6pKRY2INNjGl_DqANT3ZPam_6zJ4I130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP75945.RA0xX85VN3KC2bqP6pKRY2INNjGl_DqANT3ZPam_6zJ4I130_provenance.
• NP77838.RA1dgw7Zrei-2HsOPgho535_YDdKpzukpeBzq-owVISL0130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77838.RA1dgw7Zrei-2HsOPgho535_YDdKpzukpeBzq-owVISL0130_provenance.
• NP83608.RA-2YfOSE0PUCX15yBRoWgnso7rX_Q-YHVOe8ZVU-uCIQ130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83608.RA-2YfOSE0PUCX15yBRoWgnso7rX_Q-YHVOe8ZVU-uCIQ130_provenance.
• NP85060.RA4D6vbhUjNeT5CT8ceEZBGuKbX4Hni8ZPgnugKkf-rBk130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85060.RA4D6vbhUjNeT5CT8ceEZBGuKbX4Hni8ZPgnugKkf-rBk130_provenance.
• NP86550.RA2GP_JTUPe8sCGXRWWLeu4TIUZD-YWPFQLo9JWOUIP9M130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86550.RA2GP_JTUPe8sCGXRWWLeu4TIUZD-YWPFQLo9JWOUIP9M130_provenance.
• NP86828.RAygVPdi80oBYtUxDL2IvXHECXG5lK-R_dAhMuRocm8Fs130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86828.RAygVPdi80oBYtUxDL2IvXHECXG5lK-R_dAhMuRocm8Fs130_provenance.
• NP88570.RA2eLA-BJ3hTHnEeIta7jH668OoicNGNUEuCYeAZDdtxU130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88570.RA2eLA-BJ3hTHnEeIta7jH668OoicNGNUEuCYeAZDdtxU130_provenance.
• NP88606.RA10KAlij7kwUTmiIUeWmLHzidCxHaEXzKQj5n4unwuQg130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88606.RA10KAlij7kwUTmiIUeWmLHzidCxHaEXzKQj5n4unwuQg130_provenance.
• NP90604.RA8R0AZJcsnaW3E_QaqmuPg1vyGfZ5A0csJhMWRDKCf1I130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90604.RA8R0AZJcsnaW3E_QaqmuPg1vyGfZ5A0csJhMWRDKCf1I130_provenance.
• NP92008.RA8pAwakIhICIy5F28ub8QFanoeoLGITlu95Iu1GTl3Zw130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92008.RA8pAwakIhICIy5F28ub8QFanoeoLGITlu95Iu1GTl3Zw130_provenance.
• NP85053.RAd_unVoCiHBtmvmp9o2jtbKVCeYN6Ew0U6SUXbOlfTR4130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85053.RAd_unVoCiHBtmvmp9o2jtbKVCeYN6Ew0U6SUXbOlfTR4130_provenance.
• NP85059.RAaHTk9ONK4Ce5COiF8NyyBR0GrN7YJQlJ-wNAs61VqwA130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85059.RAaHTk9ONK4Ce5COiF8NyyBR0GrN7YJQlJ-wNAs61VqwA130_provenance.
• NP85671.RAbzuDfDuaKNmfNBdj8AbnK3ITfGD7_k9L_KKQ-AkBxUA130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85671.RAbzuDfDuaKNmfNBdj8AbnK3ITfGD7_k9L_KKQ-AkBxUA130_provenance.
• NP89154.RAaSxfaKBz5IYBIQ_tks2jF97532_97MLNTIpmc1A98XU130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89154.RAaSxfaKBz5IYBIQ_tks2jF97532_97MLNTIpmc1A98XU130_provenance.
• NP90920.RAYFdBezeMvs45FroUxl8h2g85vrzGDnCJn9NgKTm1AJg130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90920.RAYFdBezeMvs45FroUxl8h2g85vrzGDnCJn9NgKTm1AJg130_provenance.
• NP91085.RATHVOaECpFsacZsx47StubJQoWATbLoVqujAT7K6KnUo130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91085.RATHVOaECpFsacZsx47StubJQoWATbLoVqujAT7K6KnUo130_provenance.
• NP55258.RAVxbqYhujKuxN_ZvRFVjPwZW8UAm74I_UV5Xz51nr96k130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55258.RAVxbqYhujKuxN_ZvRFVjPwZW8UAm74I_UV5Xz51nr96k130_provenance.
• NP63110.RAbemic54_R3xoOeLYh1Ty-FveJ6iJyRNQAljMX3INjJs130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63110.RAbemic54_R3xoOeLYh1Ty-FveJ6iJyRNQAljMX3INjJs130_provenance.
• NP64633.RACy2AlUB3QScvvy59NZUg9NlZbYheDrEU9dt0TQuphrc130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64633.RACy2AlUB3QScvvy59NZUg9NlZbYheDrEU9dt0TQuphrc130_provenance.
• NP78375.RAQKxBgp-YfTrLO5r3qKupC6wDTLdQ1ygLmehCDzOJE8w130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP78375.RAQKxBgp-YfTrLO5r3qKupC6wDTLdQ1ygLmehCDzOJE8w130_provenance.
• NP83085.RAeatPYyQxpD9yCZW58wmOPyPmElp6svumYlNwtzxX2ug130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83085.RAeatPYyQxpD9yCZW58wmOPyPmElp6svumYlNwtzxX2ug130_provenance.
• NP83283.RAfj6DJi-HuFLa2dcHEUtiotLDGidOg7MK1gGdDUZ_5V4130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83283.RAfj6DJi-HuFLa2dcHEUtiotLDGidOg7MK1gGdDUZ_5V4130_provenance.
• NP84495.RAfOtGxy2ooJC880nEAD1hcboAnw5trvd5_TKUEkEXN38130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84495.RAfOtGxy2ooJC880nEAD1hcboAnw5trvd5_TKUEkEXN38130_provenance.
• NP92509.RAwszyn3pQwKEOl3ogXnsK8HEjj0UBv7xRPjZOXy638go130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92509.RAwszyn3pQwKEOl3ogXnsK8HEjj0UBv7xRPjZOXy638go130_provenance.
• NP92635.RA5EA0EXkj-2JLR9GKPcMvWTLEGoipknpOPZJiR-Oakjw130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92635.RA5EA0EXkj-2JLR9GKPcMvWTLEGoipknpOPZJiR-Oakjw130_provenance.
• NP63058.RAtgnC2oFZWaWx0lLsqJS0L12oMgD9yEePt_HPao3xD4A130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63058.RAtgnC2oFZWaWx0lLsqJS0L12oMgD9yEePt_HPao3xD4A130_provenance.
• NP64468.RAiuawfsLVA0K2okwvTcNevTFLWK_nPyoLEYyDQouv6Ys130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64468.RAiuawfsLVA0K2okwvTcNevTFLWK_nPyoLEYyDQouv6Ys130_provenance.
• NP85648.RAgF_EJUDdk7gAuTy9AsocRN_QEiQTiK84UlRMMLEL4V8130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85648.RAgF_EJUDdk7gAuTy9AsocRN_QEiQTiK84UlRMMLEL4V8130_provenance.
• NP87213.RAuAzuvLyU0aH2JN7bG1-rvru9kZ5RrIRXqZlHuy1Yi2o130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87213.RAuAzuvLyU0aH2JN7bG1-rvru9kZ5RrIRXqZlHuy1Yi2o130_provenance.
• NP87771.RAo2tStWdxL8W-8DJ-QSgky0dP9e6_QvouiXVorUn9cao130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87771.RAo2tStWdxL8W-8DJ-QSgky0dP9e6_QvouiXVorUn9cao130_provenance.
• NP87982.RAsFdgCF0Nw9E12tUGYmSt-n3jl2V0WcEy_HplSIy7RJQ130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87982.RAsFdgCF0Nw9E12tUGYmSt-n3jl2V0WcEy_HplSIy7RJQ130_provenance.
• NP90385.RAq4B3mfn6-pREdkrNU6bZPjlAaNPdEk0EEFoY_q68x7c130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90385.RAq4B3mfn6-pREdkrNU6bZPjlAaNPdEk0EEFoY_q68x7c130_provenance.
• NP59139.RAGNVH4wRNw2FJmVzn08YL2TpkhGhyTE5xtTbwVNKM4Kw130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59139.RAGNVH4wRNw2FJmVzn08YL2TpkhGhyTE5xtTbwVNKM4Kw130_provenance.
• NP59279.RAJmTHb32gpqb7IqBDi2kfYvzxjEOEr0M1kEBXSqFU6M4130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP59279.RAJmTHb32gpqb7IqBDi2kfYvzxjEOEr0M1kEBXSqFU6M4130_provenance.
• NP70661.RAN6YNVTax_eKgKjj6CwQIGZdAl0KoBXKsFRUkR5Y8YWM130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP70661.RAN6YNVTax_eKgKjj6CwQIGZdAl0KoBXKsFRUkR5Y8YWM130_provenance.
• NP71005.RAo-VGjyXG_-cEXlPpiLcq-YvVXND0kkpSj0TRU9t7NIk130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71005.RAo-VGjyXG_-cEXlPpiLcq-YvVXND0kkpSj0TRU9t7NIk130_provenance.
• NP79278.RAikUonuxeZkESLkEpo55JyJsq_ycjFzORj4SQn1b5icw130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79278.RAikUonuxeZkESLkEpo55JyJsq_ycjFzORj4SQn1b5icw130_provenance.
• NP82957.RAiKsEM5cJPg4oAiN4kzzhktILLuGgAar5MVj11R9Ccp8130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82957.RAiKsEM5cJPg4oAiN4kzzhktILLuGgAar5MVj11R9Ccp8130_provenance.
• NP83115.RAvM4AxP2oKMZ_hci53uwqzP9twiwFoGlrRxwrhouVm5U130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83115.RAvM4AxP2oKMZ_hci53uwqzP9twiwFoGlrRxwrhouVm5U130_provenance.
• NP83977.RAjPKGfqWcrkJ1mldcDzYF4Ugf7i1QQrSJcmEmrZvVNrQ130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83977.RAjPKGfqWcrkJ1mldcDzYF4Ugf7i1QQrSJcmEmrZvVNrQ130_provenance.
• NP84589.RAnHG_-fyGCRRKvWJczx12o2D6rW6WE0GPjm01Mb-Uve8130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84589.RAnHG_-fyGCRRKvWJczx12o2D6rW6WE0GPjm01Mb-Uve8130_provenance.
• NP84749.RAuiGIz_na20BVPGwAK-fTN7T7JeOMq94ptb2Kl5H7Z2s130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84749.RAuiGIz_na20BVPGwAK-fTN7T7JeOMq94ptb2Kl5H7Z2s130_provenance.
• NP77417.RAM2JIJlU6WLD-3UEN3IO2ogW6Bd44fK7Rm8OUgXssFME130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77417.RAM2JIJlU6WLD-3UEN3IO2ogW6Bd44fK7Rm8OUgXssFME130_provenance.
• NP80661.RAKN6XFJRFNkIQ8fwBeSFj7d344uYZtZKAqGTTDEeiN3o130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80661.RAKN6XFJRFNkIQ8fwBeSFj7d344uYZtZKAqGTTDEeiN3o130_provenance.
• NP84503.RALUrhH-S5hzVeRUAkFEc16IvKyyca3r1-eAdFb_WVwgU130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84503.RALUrhH-S5hzVeRUAkFEc16IvKyyca3r1-eAdFb_WVwgU130_provenance.
• NP85013.RAPxUDE_66PcE1G3hk9VjyDbCI0Shvao_d5IQ8q4FMvgw130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85013.RAPxUDE_66PcE1G3hk9VjyDbCI0Shvao_d5IQ8q4FMvgw130_provenance.
• NP85665.RAJL_uD-cvTz9zrk4ZnLS-kwxEhsNAXyytOGCoF-hKg74130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85665.RAJL_uD-cvTz9zrk4ZnLS-kwxEhsNAXyytOGCoF-hKg74130_provenance.
• NP87843.RAF5T8aNCQ3qhBx0Q6toQWv2_kEOxdB7-i9EMik8XPebA130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87843.RAF5T8aNCQ3qhBx0Q6toQWv2_kEOxdB7-i9EMik8XPebA130_provenance.
• NP88998.RAJbN6f7iKCe9XwO9oIEonQnd9mkqzJCfz7Ee3NfZRvsg130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88998.RAJbN6f7iKCe9XwO9oIEonQnd9mkqzJCfz7Ee3NfZRvsg130_provenance.
• NP90080.RAP-E-IjQEjsGOi4Gy3BbDxWeVnE64o3_LJ3nLW4rZzXw130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90080.RAP-E-IjQEjsGOi4Gy3BbDxWeVnE64o3_LJ3nLW4rZzXw130_provenance.
• NP90485.RANpdxwGUV5OjZ5VDLgJCtI9hdn0IyL5xvLIsS8Km3mpE130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90485.RANpdxwGUV5OjZ5VDLgJCtI9hdn0IyL5xvLIsS8Km3mpE130_provenance.
• NP92584.RAL7_j-iSrUPQb9dSrTuJ6XDmnMPwkE3Mqf6Yylw2pq6o130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92584.RAL7_j-iSrUPQb9dSrTuJ6XDmnMPwkE3Mqf6Yylw2pq6o130_provenance.
• NP820786.RATfSFboktxT1U1T8fDPY_r9GoDPsctmUbUeh_cQv1nS0130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820786.RATfSFboktxT1U1T8fDPY_r9GoDPsctmUbUeh_cQv1nS0130_provenance.
• NP820787.RAgWGZbGUqAbgZ03-KUp_1TNG7aKFKrm-iOJwNBebvMOo130_assertion description "[Adding SNPs previously associated with fasting glucose, insulin, lipids or obesity to a genetic risk score for type 2 diabetes significantly increases the power to discriminate between people with and without clinically manifest type 2 diabetes compared with a model including only conventional type 2 diabetes loci.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820787.RAgWGZbGUqAbgZ03-KUp_1TNG7aKFKrm-iOJwNBebvMOo130_provenance.